Bios Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
30
- Portfolio
-
8
- Exits
-
15
Bios Partners General Information
Company Description
Founded in 2014, Bios Partners is a venture capital investment firm based in Fort Worth, Texas. The firm seeks to invest in seed-stage, early-stage, growth-stage, and later-stage companies. The firm seeks to invest in the healthcare and life sciences sectors in the United States, specifically in the New England, Southeast, South, and West Coast regions. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.biospartners.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1751 River Run
- Suite 400
- Fort Worth, TX 76107
- United States
Bios Partners Investments (30)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Renibus Therapeutics | 17-Jul-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 3 | ||
| Trefoil Therapeutics | 06-May-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Bobcatbio | 20-Dec-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| ONL Therapeutics | 16-Sep-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| ONL Therapeutics | 12-Mar-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Bobcatbio | 14-Feb-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| IN8bio | 13-Dec-2023 | Biotechnology | Generating Revenue | |||
| Rein Therapeutics | 31-Oct-2023 | Drug Discovery | Generating Revenue | |||
| I-Lumen Scientific | 15-Nov-2022 | Later Stage VC | Other Pharmaceuticals and Biotechnology | Clinical Trials - General | ||
| Opus Genetics (acquired in 2024)) | 20-Aug-2021 | Seed Round | Drug Discovery | Generating Revenue |
Bios Partners Exits (15)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Rein Therapeutics | 04-May-2026 | Public Investment 2nd Offering | |
| 410 Medical | 01-Apr-2026 | ||
| Opus Genetics (acquired in 2024)) | 22-Oct-2024 | ||
| Actuate Therapeutics | 12-Aug-2024 | ||
| Lung Therapeutics | 31-Oct-2023 | ||
| Azitra | 15-Jun-2023 | ||
| Abilitech Medical | 01-Jan-2023 | ||
| Cognition Therapeutics | 14-Nov-2022 | ||
| IN8bio | 15-Aug-2022 | Public Investment 2nd Offering | |
| Cognition Therapeutics | 08-Oct-2021 | IPO |
Bios Partners Investments by Industry, Year, and Region
Bios Partners Co-Investors (22)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alafi Capital Company | 1 |
|
|
||
| Johnson & Johnson JJDC |
|
|
|||
| Novartis |
|
|
|||
| Novartis Venture Fund |
|
|
|||
| Wexford Capital |
|
|
Bios Partners FAQs
-
What is Bios Partners?
Founded in 2014, Bios Partners is a venture capital investment firm based in Fort Worth, Texas.
-
When was Bios Partners founded?
Bios Partners was founded in 2014.
-
Where is Bios Partners headquartered?
Bios Partners is headquartered in Fort Worth, TX.
-
What is Bios Partners's total asset value?
Bios Partners has around in total assets under management.
-
How many investments has Bios Partners made?
Bios Partners has made 30 investments.
-
What has Bios Partners invested in?
Bios Partners has made numerous investments in companies like Renibus Therapeutics, Trefoil Therapeutics, and Bobcatbio within the Drug Discovery industry.
-
What has Bios Partners invested in recently?
Bios Partners's latest investment was on 17-Jul-2025 in Renibus Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process